Wave Life Sciences Ltd. - Laporan Laba Rugi (TTM)

Wave Life Sciences Ltd.
US ˙ NasdaqGM ˙ SG9999014716

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Wave Life Sciences Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 13 20 16 16 49 41 43 40 4 4 15 37 85 113 113 110 54 108 105 94
Change (%) 53.99 -20.73 -1.58 210.49 -15.78 4.27 -5.62 -89.64 -12.60 306.36 146.55 133.84 32.54 -0.35 -2.14 -51.48 102.02 -3.11 -10.48
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 150 124 116 117 119 122 116 114 111 116 119 123 127 130 132 140 149 160 167 170
Change (%) -17.24 -6.25 0.13 2.41 2.10 -4.86 -1.64 -3.08 4.81 3.03 3.00 3.31 2.36 1.90 5.34 6.85 7.09 4.49 1.84
% of Revenue 1,150.78 618.44 731.34 744.06 245.42 297.52 271.46 282.91 2,647.64 3,175.01 805.00 336.29 148.57 114.74 117.33 126.30 278.14 147.44 159.00 180.88
Gross Operating Profit -137 -104 -100 -101 -71 -81 -73 -74 -106 -112 -105 -86 -42 -17 -20 -29 -96 -51 -62 -76
Change (%) -24.02 -3.46 0.41 -29.90 14.39 -9.48 0.68 44.25 5.49 -6.84 -17.36 -51.93 -59.77 17.12 48.53 228.68 -46.20 20.51 22.72
% of Revenue -1,050.78 -518.44 -631.34 -644.06 -145.42 -197.52 -171.46 -182.91 -2,547.64 -3,075.01 -705.00 -236.29 -48.57 -14.74 -17.33 -26.30 -178.14 -47.44 -59.00 -80.88
SG&A 47 43 40 40 44 46 48 50 49 51 50 50 51 51 53 55 57 59 64 68
Change (%) -8.77 -6.86 1.93 8.31 5.48 4.98 3.80 -2.66 3.29 -0.28 -1.07 3.05 -0.12 2.56 3.86 3.50 4.37 8.15 5.79
% of Revenue 357.39 211.73 248.76 257.62 89.87 112.55 113.31 124.62 1,171.33 1,384.30 339.72 136.31 60.07 45.27 46.59 49.45 105.49 54.50 60.83 71.88
R&D 7 7 7 7
Change (%) 0.00 0.00 0.00
% of Revenue 33.77 42.59 43.27 13.94
OpEx 197 173 163 164 170 168 164 164 159 166 170 173 178 181 185 194 206 219 231 237
Change (%) -11.79 -6.16 0.57 3.77 -1.11 -2.16 -0.04 -2.95 4.34 2.03 1.79 3.23 1.65 2.09 4.92 5.91 6.34 5.48 2.93
% of Revenue 1,508.17 863.94 1,022.69 1,044.95 349.23 410.07 384.78 407.53 3,818.97 4,559.30 1,144.72 472.60 208.64 160.01 163.92 175.74 383.63 201.94 219.83 252.76
Operating Income -184 -153 -147 -148 -121 -127 -122 -124 -155 -163 -155 -136 -93 -68 -72 -84 -152 -110 -126 -144
Change (%) -16.46 -4.25 0.80 -18.11 4.78 -4.23 1.92 25.24 4.80 -4.80 -12.07 -31.82 -26.79 6.14 15.97 81.68 -27.39 13.90 14.12
% of Revenue -1,408.17 -763.94 -922.69 -944.95 -249.23 -310.07 -284.78 -307.53 -3,718.97 -4,459.30 -1,044.72 -372.60 -108.64 -60.01 -63.92 -75.74 -283.63 -101.94 -119.83 -152.76
Interest Expense
Change (%)
% of Revenue
Net Income -178 -150 -145 -143 -116 -122 -118 -120 -153 -162 -151 -131 -85 -58 -62 -73 -143 -97 -112 -130
Change (%) -15.73 -3.35 -1.22 -18.77 5.16 -3.80 2.15 27.28 5.84 -6.43 -13.34 -35.25 -32.31 7.22 19.17 93.94 -31.93 15.79 15.62
% of Revenue -1,364.40 -746.68 -910.29 -913.62 -239.01 -298.42 -275.31 -297.98 -3,662.25 -4,434.72 -1,021.14 -358.93 -99.39 -50.76 -54.61 -66.50 -265.84 -89.57 -107.04 -138.24

Source: Capital IQ

Other Listings
DE:1U5 € 6.35
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista